IRTC insider trading

NasdaqGS Healthcare

iRhythm Holdings, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
853
Last 90 days
66
Buys / sells
1% / 49%
Market cap
$4.49B

About iRhythm Holdings, Inc.

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within our ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Company website: www.irhythmtech.com

IRTC insider activity at a glance

FilingIQ has scored 853 insider transactions for IRTC since Oct 19, 2016. The most recent filing in our index is dated May 11, 2026.

Across the full history, 7 open-market purchases and 422 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on IRTC insider trades is 63.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest IRTC Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Top insiders trading IRTC

Frequently asked

How many insider trades does FilingIQ track for IRTC?
FilingIQ tracks 853 Form 4 insider transactions for IRTC (iRhythm Holdings, Inc.), covering filings from Oct 19, 2016 onwards. 66 of those were filed in the last 90 days.
Are IRTC insiders net buyers or net sellers?
Across the full Form 4 history for IRTC, 7 transactions (1%) were open-market purchases and 422 (49%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does IRTC insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is IRTC in?
iRhythm Holdings, Inc. (IRTC) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $4.49B.

Methodology & sources

Every IRTC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.